Source: The Journal of Clinical Endocrinology & Metabolism
Key Takeaway: Nationwide reimbursement of real-time CGM improved HbA1c, fear of hypoglycemia, and QOL as well as economic indicators including work absenteeism and hospital admissions for acute diabetes complications.
|The Value of rtCGM: Reduction in Hospitalizations and Work Absenteeism|
|Pre-Reimbursement for rtCGM||Post-Reimbursement for rtCGM||P Value|
|(n = 496)||(n = 379)|
|Hospitalizations due to hypoglycemia and/or ketoacidosis||77 (16%)||14 (4%)||<0.0005|
|Hospitalizations due to hypoglycemia||59 (11%)||12 (3%)||<0.0005|
|Hospitalizations due to ketoacidosis||23 (5%)||4 (1%)||0.092|
|Work absenteesim*||123 (25%)||36 (9%)||<0.0005|
|Days (per 100 patient years) of|
|Hospitalizations due to hypoglycemia and/or ketoacidosis||53.5||17.8||<0.0005|
|Hospitalizations due to hypoglycemia||38.5||12.5||0.001|
|Hospitalizations due to ketoacidosis||14.9||5.3||0.220|
Data are n (%).
*Work absenteeism of at least half a day. Patient-reported hospital admissions were validated by clinicians.
Reference: Charleer S, et al. Clin Endocrinol Metab. 2018;103(3):1224–1232
Reference: Charleer S, Mathieu C, Nobels F, et al. J Clin Endocrinol Metab. 2018;103(3):1224-1232.